Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.

Benzinga

Could simple blood tests identify cancer earlier?

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

LiveScience

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review processes for products that align with critical U.S. national health priorities, reducing review times from 10 to 12 months…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026

On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the most-favored-nation, or MFN price.

Benzinga

Protein powders and shakes contain high amounts of lead, new report says – a pharmacologist explains the data

Powder and ready-to-drink protein sales have exploded, reaching over US$32 billion globally from 2024 to 2025. Increasingly, consumers are using these protein sources daily.

The Conversation

What To Do If There’s a Shortage of Your Medications Due To Tariffs

Should you end up facing a shortage in your medications due to tariffs, or for other market-related availability issues, what should you do?

GOBankingRates

FDA unveils drugs to receive expedited review in support of 'national priorities'

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

“Lean Lipo” Is the Newest Addition to the Body Contouring Toolkit

Meet "lean lipo"—the newest addition to the body contouring toolkit.

Marie Claire

The protein craze is heavy metal, literally: bombshell investigation finds unsafe lead amounts in two-thirds of top powders for sale

Paris Martineau said Consumer Reports found “concerning levels” of heavy metals in a 2010 investigation, but the risks have been growing ever since.

Fortune

This ‘Strong Buy’ Stock Has More Than Tripled Today. Should You Buy It Here?

Praxis shares soar as the biotech firm reports promising late-stage results for ulixacaltamide. Here’s why it may not be too late to invest in PRAX shares.

Barchart

Novartis Strengthens Kidney Disease Pipeline With Promising Data

Novartis A/S (NYSE:NVS) on Thursday shared final results from the APPLAUSE-IgAN Phase 3 study evaluating Fabhalta (iptacopan) in adults with IgA nephropathy (IgAN).

Benzinga

16 cinnamon brands to avoid after high levels of lead found in spice blends

Four brands have been added to the FDA’s ongoing health alert within the last week

The Independent UK

There have currently been no reported illnesses as a result of the contamination, the FDA reports

The Independent UK

Powering up? Unsafe levels of lead found in top protein powder mixes, study finds

Supplements like protein powders are not regulated by the U.S. Food and Drug Administration

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Kids Ain't Cheap

10 Children’s Medications That Were Recently Recalled

Image source: shutterstock.com

Benzinga

FDA Delays Decision Date For Denali Therapeutics' Lead Drug Candidate

The U.S. Food and Drug Administration extended on Monday Denali Therapeutics Inc.’s (NASDAQ:DNLI) review timeline of the Biologics License Application (BLA), seeking accelerated approval of tividenofusp alfa for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome.

Benzinga

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

On Tuesday, the U.S. Food and Drug Administration (FDA) accepted Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) resubmission of the Biologics License Application (BLA) for Kresladi (marnetegragene autotemcel; marne-cel), a lentiviral vector (LV)-based investigational gene therapy for severe Leukocyte Adhesion Deficiency-I (LAD-I).

Benzinga

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Telix Pharmaceuticals (NASDAQ:TLX) updated on Tuesday its commercial and operational performance for the third quarter of fiscal 2025.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease

Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year

The Independent UK

State urges residents to check freezers for radioactive shrimp after damning investigation into Indonesian farm

FDA has added to list of brands and products that may have been contaminated with cesium-137, a human-made radioactive substance that can cause cancer

MarketBeat

Why Congress Is Buying Intuitive Surgical Ahead of Earnings

Intuitive Surgical has attracted recent congressional buying ahead of its next quarterly earnings results, implying a new potential bull run

The Independent UK

Doritos and Cheetos are getting a makeover with ingredient change — and new flavor line

In addition to new recipes, PepsiCo hopes to introduce fresh packaging for its beloved snacks

Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst

Needham initiated coverage on Monday for GH Research PLC (NASDAQ:GHRS), citing the company’s lead drug candidate, GH-001, which had demonstrated impressive efficacy in Phase 2 versus competition.

Benzinga

Why Is Scholar Rock Stock Trading Lower On Monday?

Scholar Rock Holding Inc. (NASDAQ:SRRK) stock is falling on Monday with a session volume of 8.19 million versus the average volume of 2.08 million, as per data from Benzinga Pro.

Saving Advice

10 Foods That Interfere with Common Senior Medications

As people age, prescription use increases—but few realize that certain everyday foods can make those medications less effective or even dangerous. The Centers for Disease...

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

Consumer Reports

228 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.